Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kim R.M. Blenman"'
Autor:
Lajos Pusztai, Sibylle Loibl, David L. Rimm, Julia Foldi, Mariya Rozenblit, Bruno V. Sinn, Carsten Denkert, Emily Reisenbichler, Denise M. Wolf, Andrea Silber, Tristen Park, Eiman Y. Ibrahim, Yalai Bai, Vesal Yaghoobi, Vignesh Gunasekharan, Xiaotong Li, Tao Qing, Thomas Karn, Michal Marczyk, Kim R.M. Blenman
Supplementary Figure from Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be6ccaec71409b8468aa9f3c2aa4931
https://doi.org/10.1158/1078-0432.22486878.v1
https://doi.org/10.1158/1078-0432.22486878.v1
Autor:
Lajos Pusztai, Christos Hatzis, Richard Kibbey, Rachel J. Perry, Jesse Rinehart, Viswanathan Muthusamy, Yulia V. Surovtseva, Sheila Umlauf, Tess A. O'Meara, Kim R.M. Blenman, Naing Lin Shan, Raghav Sehgal, Julia Foldi, Tao Qing, David Casadevall, Vignesh Gunasekharan, Michal Marczyk
Supplementary Table from Comprehensive Analysis of Metabolic Isozyme Targets in Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02fadbca40e62cd5a24e6225e03953e7
https://doi.org/10.1158/0008-5472.22431361
https://doi.org/10.1158/0008-5472.22431361
Autor:
Lajos Pusztai, Christos Hatzis, Richard Kibbey, Rachel J. Perry, Jesse Rinehart, Viswanathan Muthusamy, Yulia V. Surovtseva, Sheila Umlauf, Tess A. O'Meara, Kim R.M. Blenman, Naing Lin Shan, Raghav Sehgal, Julia Foldi, Tao Qing, David Casadevall, Vignesh Gunasekharan, Michal Marczyk
Metabolic reprogramming is a hallmark of malignant transformation, and loss of isozyme diversity (LID) contributes to this process. Isozymes are distinct proteins that catalyze the same enzymatic reaction but can have different kinetic characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6acd4eaa9862a9f641b365a93919fb5
https://doi.org/10.1158/0008-5472.c.6513877.v1
https://doi.org/10.1158/0008-5472.c.6513877.v1
Autor:
Lajos Pusztai, Christos Hatzis, Richard Kibbey, Rachel J. Perry, Jesse Rinehart, Viswanathan Muthusamy, Yulia V. Surovtseva, Sheila Umlauf, Tess A. O'Meara, Kim R.M. Blenman, Naing Lin Shan, Raghav Sehgal, Julia Foldi, Tao Qing, David Casadevall, Vignesh Gunasekharan, Michal Marczyk
Supplementary Figure from Comprehensive Analysis of Metabolic Isozyme Targets in Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b2e77144a782ef9db320a82c7bd8bcd
https://doi.org/10.1158/0008-5472.22431385.v1
https://doi.org/10.1158/0008-5472.22431385.v1
Autor:
Lajos Pusztai, Christos Hatzis, Richard Kibbey, Rachel J. Perry, Jesse Rinehart, Viswanathan Muthusamy, Yulia V. Surovtseva, Sheila Umlauf, Tess A. O'Meara, Kim R.M. Blenman, Naing Lin Shan, Raghav Sehgal, Julia Foldi, Tao Qing, David Casadevall, Vignesh Gunasekharan, Michal Marczyk
Supplementary Data from Comprehensive Analysis of Metabolic Isozyme Targets in Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::494cd710ff333b994c32300112fe6844
https://doi.org/10.1158/0008-5472.22431394
https://doi.org/10.1158/0008-5472.22431394
Autor:
Lajos Pusztai, Sibylle Loibl, David L. Rimm, Julia Foldi, Mariya Rozenblit, Bruno V. Sinn, Carsten Denkert, Emily Reisenbichler, Denise M. Wolf, Andrea Silber, Tristen Park, Eiman Y. Ibrahim, Yalai Bai, Vesal Yaghoobi, Vignesh Gunasekharan, Xiaotong Li, Tao Qing, Thomas Karn, Michal Marczyk, Kim R.M. Blenman
Purpose:We examined gene expression, germline variant, and somatic mutation features associated with pathologic response to neoadjuvant durvalumab plus chemotherapy in basal-like triple-negative breast cancer (bTNBC).Experimental Design:Germline and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51aacd7964811b0490edb405ffb43696
https://doi.org/10.1158/1078-0432.c.6532407.v1
https://doi.org/10.1158/1078-0432.c.6532407.v1
Autor:
David L. Rimm, Harriet M. Kluger, Daniel Zelterman, Kim R.M. Blenman, Maria I. Toki, Balazs Acs, James W. Smithy, Wei Wei, Pok Fai Wong
Purpose:Because durable response to programmed cell death 1 (PD-1) inhibition is limited to a subset of melanoma patients, new predictive biomarkers could have clinical utility. We hypothesize that pretreatment tumor-infiltrating lymphocyte (TIL) pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f48284dcb983aef88ac0fa6b5693df51
https://doi.org/10.1158/1078-0432.c.6528002.v1
https://doi.org/10.1158/1078-0432.c.6528002.v1
Autor:
Kim R.M. Blenman, Michal Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y. Ibrahim, Tristen Park, Andrea Silber, Denise M. Wolf, Emily Reisenbichler, Carsten Denkert, Bruno V. Sinn, Mariya Rozenblit, Julia Foldi, David L. Rimm, Sibylle Loibl, Lajos Pusztai
Publikováno v:
Clin Cancer Res
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 12
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 12
Purpose: We examined gene expression, germline variant, and somatic mutation features associated with pathologic response to neoadjuvant durvalumab plus chemotherapy in basal-like triple-negative breast cancer (bTNBC). Experimental Design: Germline a
Publikováno v:
Advances in Cancer Research ISBN: 9780323900874
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35af74cdd82724d720b20414f6df24a7
https://doi.org/10.1016/bs.acr.2022.02.006
https://doi.org/10.1016/bs.acr.2022.02.006
Autor:
Shawn M. Hercules, Xiyu Liu, Blessing I. Bassey-Archibong, Desiree H.A. Skeete, Suzanne Smith Connell, Adetola Daramola, Adekunbiola A.F. Banjo, Godwin Ebughe, Thomas Agan, Ima-Obong Ekanem, Joe E. Udosen, Christopher Obiorah, Aaron C. Ojule, Michael A. Misauno, Ayuba M. Dauda, Ejike C. Egbujo, Jevon C. Hercules, Amna Ansari, Ian Brain, Christine MacColl, Yili Xu, Yuxin Jin, Sharon Chang, John D. Carpten, André Bédard, Gregory R. Pond, Kim R.M. Blenman, Zarko Manojlovic, Juliet M. Daniel
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-142
Women of African ancestry (WAA) are disproportionately affected by the aggressive triple negative breast cancer (TNBC) subtype that is often associated with high recurrence rates and metastasis. Although there is a high prevalence of TNBC across West